{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:17:12Z","timestamp":1786987032088,"version":"build-2736575974"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clindermatol.2025.09.010","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:39:42Z","timestamp":1758767982000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Herpes simplex virus (update on dermatologic aspects of sexually transmitted disease and human immunodeficiency virus)"],"prefix":"10.1016","volume":"44","author":[{"given":"Emily","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clindermatol.2025.09.010_bib0001","doi-asserted-by":"crossref","first-page":"vex026","DOI":"10.1093\/ve\/vex026","article-title":"Network analysis of the hominin origin of herpes simplex virus 2 from fossil data","volume":"3","author":"Underdown","year":"2017","journal-title":"Virus Evol"},{"issue":"5","key":"10.1016\/j.clindermatol.2025.09.010_bib0002","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.clindermatol.2025.09.010_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001875","article-title":"The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study","volume":"5","author":"Looker","year":"2020","journal-title":"BMJ Glob Health"},{"issue":"19","key":"10.1016\/j.clindermatol.2025.09.010_bib0004","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM199911043411904","article-title":"A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group","volume":"341","author":"Langenberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0005","first-page":"24","article-title":"Case study: type-specific HSV serology and the correct diagnosis of first-episode genital herpes during pregnancy","volume":"9","author":"Brown","year":"2002","journal-title":"Herpes"},{"issue":"7350","key":"10.1016\/j.clindermatol.2025.09.010_bib0006","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.324.7350.1366","article-title":"Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years","volume":"324","author":"Scoular","year":"2002","journal-title":"BMJ"},{"issue":"Suppl 4","key":"10.1016\/j.clindermatol.2025.09.010_bib0007","first-page":"iv31","article-title":"Genital herpes","volume":"82","author":"Geretti","year":"2006","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0008","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1258\/ijsa.2008.008386","article-title":"HSV-1 genital infection rare in men over the age of 35 years","volume":"20","author":"Sundaram","year":"2009","journal-title":"Int J STD AIDS"},{"issue":"11","key":"10.1016\/j.clindermatol.2025.09.010_bib0009","doi-asserted-by":"crossref","first-page":"847","DOI":"10.7326\/0003-4819-121-11-199412010-00004","article-title":"Recurrence rates in genital herpes after symptomatic first-episode infection","volume":"121","author":"Benedetti","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-131-1-199907060-00004","article-title":"Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time","volume":"131","author":"Benedetti","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.clindermatol.2025.09.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115221","article-title":"Performance characteristics of the SpeeDx PlexPCR VHS assay for the molecular detection of herpes simplex virus, varicella zoster virus, and Treponema pallidum in lesion swabs","volume":"99","author":"Goldstein","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clindermatol.2025.09.010_bib0012","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/sextrans-2019-054181","article-title":"on behalf of BHSIG. UK Sexual health clinics may be missing atypical syphilis","volume":"96","author":"Harrison","year":"2020","journal-title":"Sex Transm Infect"},{"issue":"2","key":"10.1016\/j.clindermatol.2025.09.010_bib0013","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/380838","article-title":"Etiology of clinical proctitis among men who have sex with men","volume":"38","author":"Klausner","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.clindermatol.2025.09.010_bib0014","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/OLQ.0000000000000022","article-title":"The etiology of infectious proctitis in men who have sex with men differs according to HIV status","volume":"40","author":"Bissessor","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.clindermatol.2025.09.010_bib0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/sextrans-2018-053936","article-title":"Symptomatic sexually transmitted proctitis in men who have sex with men","volume":"95","author":"Pinto-Sander","year":"2019","journal-title":"Sex Transm Infect"},{"issue":"7","key":"10.1016\/j.clindermatol.2025.09.010_bib0016","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1056\/NEJMicm1701668","article-title":"Eczema herpeticum","volume":"377","author":"Micali","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2025.09.010_sbref0017","series-title":"StatPearls","article-title":"Eczema Herpeticum","author":"Xiao","year":"2023"},{"issue":"6","key":"10.1016\/j.clindermatol.2025.09.010_bib0018","doi-asserted-by":"crossref","first-page":"xv","DOI":"10.1111\/j.0022-202X.2005.23764.x","article-title":"Herpes-associated erythema multiforme","volume":"124","author":"Weston","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.clindermatol.2025.09.010_bib0019","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0190-9622(83)80003-6","article-title":"Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes","volume":"8","author":"Huff","year":"1983","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaad.2009.06.046","article-title":"Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007","volume":"62","author":"Wetter","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.clindermatol.2025.09.010_bib0021","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.1993.tb00232.x","article-title":"Recurrent erythema multiforme: clinical features and treatment in a large series of patients","volume":"128","author":"Schofield","year":"1993","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.clindermatol.2025.09.010_bib0022","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/sti.2004.013110","article-title":"National survey of diagnostic services for genital herpes","volume":"81","author":"Geretti","year":"2005","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.clindermatol.2025.09.010_bib0023","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/sti.78.3.160","article-title":"Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision","volume":"78","author":"Scoular","year":"2002","journal-title":"Sex Transm Infect"},{"issue":"9","key":"10.1016\/j.clindermatol.2025.09.010_bib0024","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1086\/379043","article-title":"Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture","volume":"188","author":"Wald","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.clindermatol.2025.09.010_bib0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ajog.2005.01.025","article-title":"Common use of inaccurate antibody assays to identify infection status with herpes simplex virus type 2","volume":"193","author":"Morrow","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.clindermatol.2025.09.010_bib0026","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1128\/jcm.31.12.3157-3164.1993","article-title":"Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections","volume":"31","author":"Ho","year":"1993","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.clindermatol.2025.09.010_bib0027","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/sti.77.4.232","article-title":"Sorting out the new HSV type specific antibody tests","volume":"77","author":"Ashley","year":"2001","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.clindermatol.2025.09.010_bib0028","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1743-422X-11-83","article-title":"Diagnosis of genital herpes simplex virus infection in the clinical laboratory","volume":"11","author":"LeGoff","year":"2014","journal-title":"Virol J"},{"issue":"4","key":"10.1016\/j.clindermatol.2025.09.010_bib0029","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00007435-200304000-00007","article-title":"Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2","volume":"30","author":"Ashley-Morrow","year":"2003","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.clindermatol.2025.09.010_bib0030","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/CDLI.6.6.826-831.1999","article-title":"Variability of the glycoprotein G gene in clinical isolates of herpes simplex virus type 1","volume":"6","author":"Rekabdar","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"issue":"12","key":"10.1016\/j.clindermatol.2025.09.010_bib0031","doi-asserted-by":"crossref","first-page":"9796","DOI":"10.1128\/JVI.73.12.9796-9802.1999","article-title":"Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations","volume":"73","author":"Liljeqvist","year":"1999","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.clindermatol.2025.09.010_bib0032","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/JCM.40.9.3245-3251.2002","article-title":"Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates","volume":"40","author":"Rekabdar","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.clindermatol.2025.09.010_bib0033","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/jmv.23668","article-title":"Novel deletion in glycoprotein G forms a cluster and causes epidemiologic spread of herpes simplex virus type 2 infection","volume":"85","author":"Daikoku","year":"2013","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.clindermatol.2025.09.010_bib0034","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1128\/JCM.37.5.1242-1246.1999","article-title":"Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera","volume":"37","author":"Eis-H\u00fcbinger","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.clindermatol.2025.09.010_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/OLQ.0000000000001603","article-title":"Characterization of serum samples with discordant results in 2 herpes simplex virus type 2 IgG assays","volume":"49","author":"Prince","year":"2022","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.clindermatol.2025.09.010_bib0036","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/sti.78.6.430","article-title":"An evidence based approach to testing for antibody to herpes simplex virus type 2","volume":"78","author":"Copas","year":"2002","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.clindermatol.2025.09.010_bib0037","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/sti.2003.007823","article-title":"Oral shedding of herpes simplex virus type 2","volume":"80","author":"Wald","year":"2004","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.clindermatol.2025.09.010_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"10.1016\/j.clindermatol.2025.09.010_bib0039","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/0956462415580512","article-title":"2014 UK national guideline for the management of anogenital herpes","volume":"26","author":"Patel","year":"2015","journal-title":"Int J STD AIDS"},{"issue":"Suppl B","key":"10.1016\/j.clindermatol.2025.09.010_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jac\/12.suppl_B.79","article-title":"Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy","volume":"12","author":"Corey","year":"1983","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.clindermatol.2025.09.010_bib0041","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00007435-199709000-00007","article-title":"Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group","volume":"24","author":"Fife","year":"1997","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.clindermatol.2025.09.010_bib0042","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00007435-198510000-00009","article-title":"Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir","volume":"12","author":"Corey","year":"1985","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.clindermatol.2025.09.010_bib0043","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0536.1998.tb05928.x","article-title":"Allergic contact dermatitis from lignocaine: report of 29 cases and review of the literature","volume":"39","author":"Weightman","year":"1998","journal-title":"Contact Dermatitis"},{"issue":"8298","key":"10.1016\/j.clindermatol.2025.09.010_bib0044","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(82)90658-4","article-title":"Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes","volume":"2","author":"Nilsen","year":"1982","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.clindermatol.2025.09.010_bib0045","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.1996.00440140169018","article-title":"A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group","volume":"156","author":"Spruance","year":"1996","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0046","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jama.1996.03540010046029","article-title":"Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group","volume":"276","author":"Sacks","year":"1996","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clindermatol.2025.09.010_bib0047","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM197707142970201","article-title":"The natural history of recurrent herpes simplex labialis: implications for antiviral therapy","volume":"297","author":"Spruance","year":"1977","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.clindermatol.2025.09.010_bib0048","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/339325","article-title":"Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection","volume":"34","author":"Wald","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.clindermatol.2025.09.010_bib0049","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/sti.78.6.435","article-title":"Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir","volume":"78","author":"Strand","year":"2002","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1086\/498521","article-title":"Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Aoki","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.clindermatol.2025.09.010_bib0051","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/339326","article-title":"Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment","volume":"34","author":"Leone","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.clindermatol.2025.09.010_bib0052","first-page":"105","article-title":"Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group","volume":"73","author":"Patel","year":"1997","journal-title":"Genitourin Med"},{"issue":"3","key":"10.1016\/j.clindermatol.2025.09.010_bib0053","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archinte.1997.00440240109016","article-title":"Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group","volume":"157","author":"Mertz","year":"1997","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.clindermatol.2025.09.010_bib0054","first-page":"457","article-title":"The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes","volume":"69","author":"Carney","year":"1993","journal-title":"Genitourin Med"},{"issue":"6","key":"10.1016\/j.clindermatol.2025.09.010_bib0055","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/sti.75.6.398","article-title":"Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection","volume":"75","author":"Patel","year":"1999","journal-title":"Sex Transm Infect"},{"issue":"8591","key":"10.1016\/j.clindermatol.2025.09.010_bib0056","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(88)91725-4","article-title":"Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes","volume":"1","author":"Mindel","year":"1988","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clindermatol.2025.09.010_bib0057","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/dkh244","article-title":"Pharmacokinetics of valaciclovir","volume":"53","author":"MacDougall","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.clindermatol.2025.09.010_bib0058","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1099-1557(199609)5:5<325::AID-PDS234>3.0.CO;2-1","article-title":"Safety of acyclovir in general practice: a review of the literature","volume":"5","author":"Girard","year":"1996","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0059","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00007435-200001000-00005","article-title":"Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection","volume":"27","author":"Chen","year":"2000","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.clindermatol.2025.09.010_bib0060","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/00002030-199211000-00012","article-title":"Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection","volume":"6","author":"Bagdades","year":"1992","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.clindermatol.2025.09.010_bib0061","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/345440","article-title":"A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level","volume":"36","author":"Wright","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.clindermatol.2025.09.010_bib0062","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/clinids\/11.3.474","article-title":"Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS","volume":"11","author":"Marks","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"11","key":"10.1016\/j.clindermatol.2025.09.010_bib0063","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/0003-4819-111-11-893","article-title":"Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?","volume":"111","author":"Sacks","year":"1989","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.clindermatol.2025.09.010_bib0064","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/infdis\/161.4.711","article-title":"Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS","volume":"161","author":"Gateley","year":"1990","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.clindermatol.2025.09.010_bib0065","doi-asserted-by":"crossref","first-page":"416","DOI":"10.7326\/0003-4819-76-3-112-6-416","article-title":"Herpes simplex virus resistant to acyclovir. A study in a tertiary care center","volume":"112","author":"Englund","year":"1990","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.clindermatol.2025.09.010_bib0066","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort","volume":"42","author":"Ratnam","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0067","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1468-1293.1999.00003.x","article-title":"Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease","volume":"1","author":"Fox","year":"1999","journal-title":"HIV Med"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0068","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcv.2004.04.002","article-title":"Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization","volume":"32","author":"Str\u00e1nsk\u00e1","year":"2005","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0069","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archinte.163.1.76","article-title":"Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics","volume":"163","author":"Reyes","year":"2003","journal-title":"Arch Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2025.09.010_bib0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13012-016-0452-0","article-title":"Proceedings of the 8th Annual Conference on the Science of Dissemination and Implementation: Washington, DC, USA. December 14-15, 2015","volume":"11","author":"Chambers","year":"2016","journal-title":"Implement Sci"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2025.09.010_bib0071","first-page":"S29","article-title":"Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS","volume":"5","author":"Safrin","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.clindermatol.2025.09.010_bib0072","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/sti.2003.007922","article-title":"Patient satisfaction with care for genital herpes: insights from a global survey","volume":"80","author":"Patrick","year":"2004","journal-title":"Sex Transm Infect"},{"issue":"8","key":"10.1016\/j.clindermatol.2025.09.010_bib0073","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/sextrans-2017-053244","article-title":"Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition","volume":"94","author":"Ramchandani","year":"2018","journal-title":"Sex Transm Infect"},{"issue":"95","key":"10.1016\/j.clindermatol.2025.09.010_bib0074","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2014.0160","article-title":"Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding","volume":"11","author":"Schiffer","year":"2014","journal-title":"J R Soc Interface"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/OLQ.0000000000000907","article-title":"The effect of hormonal contraception and menstrual cycle timing on genital herpes simplex virus-2 shedding and lesions","volume":"46","author":"Micks","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.clindermatol.2025.09.010_bib0076","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bbi.2011.06.003","article-title":"The effects of daily distress and personality on genital HSV shedding and lesions in a randomized, double-blind, placebo-controlled, crossover trial of acyclovir in HSV-2 seropositive women","volume":"25","author":"Strachan","year":"2011","journal-title":"Brain Behav Immun"},{"issue":"2","key":"10.1016\/j.clindermatol.2025.09.010_bib0077","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41435-018-0013-4","article-title":"Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2)","volume":"20","author":"Kleinstein","year":"2019","journal-title":"Genes Immun"},{"issue":"13","key":"10.1016\/j.clindermatol.2025.09.010_bib0078","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archinternmed.2009.177","article-title":"A pooled analysis of the effect of condoms in preventing HSV-2 acquisition","volume":"169","author":"Martin","year":"2009","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.clindermatol.2025.09.010_bib0079","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cid\/civ908","article-title":"Effect of condom use on per-act HSV-2 transmission risk in HIV-1, HSV-2-discordant couples","volume":"62","author":"Magaret","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"24","key":"10.1016\/j.clindermatol.2025.09.010_bib0080","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1001\/jama.285.24.3100","article-title":"Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women","volume":"285","author":"Wald","year":"2001","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.clindermatol.2025.09.010_bib0081","doi-asserted-by":"crossref","first-page":"707","DOI":"10.7326\/0003-4819-143-10-200511150-00007","article-title":"The relationship between condom use and herpes simplex virus acquisition","volume":"143","author":"Wald","year":"2005","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.clindermatol.2025.09.010_bib0082","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.olq.0000204723.15765.91","article-title":"Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding","volume":"33","author":"Wald","year":"2006","journal-title":"Sex Transm Dis"},{"issue":"8","key":"10.1016\/j.clindermatol.2025.09.010_bib0083","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1086\/424519","article-title":"Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract","volume":"190","author":"Gupta","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0084","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa035144","article-title":"Once-daily valacyclovir to reduce the risk of transmission of genital herpes","volume":"350","author":"Corey","year":"2004","journal-title":"N Engl J Med"},{"issue":"1 Pt 1","key":"10.1016\/j.clindermatol.2025.09.010_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00002","article-title":"Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir","volume":"124","author":"Wald","year":"1996","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.clindermatol.2025.09.010_bib0086","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1172\/JCI119237","article-title":"Frequent genital herpes simplex virus 2 shedding in immunocompetent women: Effect of acyclovir treatment","volume":"99","author":"Wald","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0087","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/504717","article-title":"Knowledge of partners\u2019 genital herpes protects against herpes simplex virus type 2 acquisition","volume":"194","author":"Wald","year":"2006","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0088","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/sti.79.1.42","article-title":"Determinants of disclosure of genital herpes to partners","volume":"79","author":"Green","year":"2003","journal-title":"Sex Transm Infect"},{"issue":"8","key":"10.1016\/j.clindermatol.2025.09.010_bib0089","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199708213370801","article-title":"The acquisition of herpes simplex virus during pregnancy","volume":"337","author":"Brown","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clindermatol.2025.09.010_bib0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.semperi.2007.01.003","article-title":"Herpes simplex virus infections of the newborn","volume":"31","author":"Kimberlin","year":"2007","journal-title":"Semin Perinatol"},{"issue":"Suppl 3","key":"10.1016\/j.clindermatol.2025.09.010_bib0091","first-page":"175A","article-title":"Preventing herpes simplex virus transmission to the neonate","volume":"11","author":"Brown","year":"2004","journal-title":"Herpes"},{"issue":"2","key":"10.1016\/j.clindermatol.2025.09.010_bib0092","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.289.2.203","article-title":"Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant","volume":"289","author":"Brown","year":"2003","journal-title":"JAMA"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25002251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25002251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:36:41Z","timestamp":1780335401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X25002251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0738081X25002251"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.09.010","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes simplex virus (update on dermatologic aspects of sexually transmitted disease and human immunodeficiency virus)","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}